Welichem announces grant of incentive stock options
September 1, 2006
BURNABY, BC, Sept. 1 /CNW/ - Welichem Biotech Inc. (the "Company") (TSX-V: WBI), is pleased to announce that the Company's board of directors approved on August 31, 2006 a grant of incentive stock options to directors, officers, employees and consultants of the Company for the purchase of up to an aggregate of 2,090,000 common shares of the Company at a price of $0.10 each until August 31, 2011. The options are granted pursuant to the terms of the Company's stock option plan, adopted by shareholders at the Company's annual general meeting held on September 30, 2005.
About Welichem Biotech Inc.
Welichem Biotech Inc. is a publicly-traded biotechnology company
developing therapeutic drugs in the fields of autoimmune diseases and cancer.
ON BEHALF OF THE BOARD
York Yingping Guo
Chief Executive Officer
For further information: York Yingping Guo,
Tel.: (604) 432-1703,
Email: yorkguo@welichem.com
